Anterior chamber factors identified for OAG

Article

Anterior chamber depth (ACD) and anterior chamber angle (ACA) were the factors identified relating to the progression of open-angle glaucoma (OAG).

Anterior chamber depth (ACD) and anterior chamber angle (ACA) were the factors identified relating to the progression of open-angle glaucoma (OAG).

A group led by Dr Zhiying Pan, Department of Ophthalmology, Interdisciplinary School of Medicine and Engineering, University of Yamanashi, Chuo Yamanashi, Japan, included 157 glaucoma patients and 26 pseudophakic eye patients used as controls in the analysis.

The team used a scanning peripheral ACD analyzer to assess ACD by numeric grades ACDG 1 to 12 and ACA twice during 2003 and 2008. The exclusion criteria was history of laser or incisional surgery, other ocular diseases that may affect visual field, visual acuity less than 20/30 and treatment with pilocarpine ophthalmic solution.

ACDG and ACA reduced from 7.2±2.3 to 6.5±2.1 and 34.2±12.6 to 28.1±10.3, respectively in the glaucoma patients, but there were no significant changes observed in patients who underwent cataract surgery.

ACD changes were greater at the peripheral region than at the central region and the reduction in ACDG was strongly linked to deep initial ACDG and wide ACA. Rapid visual field deterioration was found in patients that had a shallow ACDG and narrow ACA.

Overall, ACDG and ACA declined with age and initial ACDG and ACA was linked to OAG progression over time.The paper for this study can be found in the Journal of Glaucoma.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.